Serving leading biopharmaceutical companies globally:

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

EMPLICITI Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: EMPLICITI

Patents:	16
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for EMPLICITI

Recent Clinical Trials for EMPLICITI

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Bristol-Myers Squibb	Phase 1/Phase 2
Multiple Myeloma Research Consortium	Phase 1/Phase 2
Mayo Clinic	Phase 2

See all EMPLICITI clinical trials

Pharmacology for EMPLICITI

Ingredient-type	Antibodies, Monoclonal
Mechanism of Action	SLAMF7-directed Antibody Interactions

Patent Text Search: US Patents for EMPLICITI

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	001	2015-11-30	Start Trial	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	2034-10-30	RX	Orphan	search
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	001	2015-11-30	Start Trial	Celgene Corporation (Summit, NJ)	2039-02-26	RX	Orphan	search
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	001	2015-11-30	Start Trial	AbbVie Stemcentrx LLC (North Chicago, IL)	2033-02-08	RX	Orphan	search
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	001	2015-11-30	Start Trial	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	2035-05-04	RX	Orphan	search
Bristol Myers Squibb	EMPLICITI	elotuzumab	INJECTABLE;INJECTION	761035	001	2015-11-30	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for EMPLICITI

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
European Patent Office	2922575	Start Trial
Russian Federation	2017118453	Start Trial
European Patent Office	2809657	Start Trial
Japan	6586412	Start Trial
South Korea	20180014716	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

McKinsey

Merck

Medtronic

Colorcon

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.